Suppr超能文献

基于简单蛋白尿的风险评分可预测经皮冠状动脉介入治疗后与对比剂相关的急性肾损伤。

A simple proteinuria-based risk score predicts contrast-associated acute kidney injury after percutaneous coronary intervention.

机构信息

Division of Cardiology, Department of Internal Medicine, Fujita Health University Bantane Hospital, 3-6-10 Otobashi, Nakagawa, Nagoya, 454-8509, Japan.

Department of Cardiovascular Medicine, Graduate School of Medicine, Gunma University, Maebashi, Japan.

出版信息

Sci Rep. 2022 Jul 19;12(1):12331. doi: 10.1038/s41598-022-16690-6.

Abstract

Contrast-associated acute kidney injury (CA-AKI) is a complication of percutaneous coronary intervention (PCI). Because proteinuria is a sentinel marker of renal dysfunction, we assessed its role in predicting CA-AKI in patients undergoing PCI. A total of 1,254 patients undergoing PCI were randomly assigned to a derivation (n = 840) and validation (n = 414) dataset. We identified the independent predictors of CA-AKI where CA-AKI was defined by the new criteria issued in 2020, by a multivariate logistic regression in the derivation dataset. We created a risk score from the remaining predictors. The discrimination and calibration of the risk score in the validation dataset were assessed by the area under the receiver-operating characteristic curves (AUC) and Hosmer-Lemeshow test, respectively. A total of 64 (5.1%) patients developed CA-AKI. The 3 variables of the risk score were emergency procedures, serum creatinine, and proteinuria, which were assigned 1 point each based on the correlation coefficient. The risk score demonstrated a good discriminative power (AUC 0.789, 95% CI 0.766-0.912) and significant calibration. It was strongly associated with the onset of CA-AKI (Cochran-Armitage test, p < 0.0001). Our risk score that included proteinuria was simple to obtain and calculate, and may be useful in assessing the CA-AKI risk before PCI.

摘要

对比剂相关急性肾损伤(CA-AKI)是经皮冠状动脉介入治疗(PCI)的一种并发症。由于蛋白尿是肾功能障碍的一个先兆标志物,我们评估了其在预测行 PCI 患者 CA-AKI 中的作用。共有 1254 例行 PCI 的患者被随机分配到推导(n=840)和验证(n=414)数据集。我们通过多元逻辑回归在推导数据集中确定了 CA-AKI 的独立预测因子,其中 CA-AKI 是根据 2020 年发布的新标准定义的。我们从其余预测因子中创建了一个风险评分。在验证数据集中,通过接收者操作特征曲线(AUC)下的面积和 Hosmer-Lemeshow 检验分别评估风险评分的区分度和校准度。共有 64 例(5.1%)患者发生 CA-AKI。风险评分的 3 个变量是紧急手术、血清肌酐和蛋白尿,根据相关系数,每个变量分别赋值 1 分。风险评分具有良好的判别能力(AUC 0.789,95%CI 0.766-0.912)和显著的校准度。它与 CA-AKI 的发生密切相关(Cochran-Armitage 检验,p<0.0001)。我们的风险评分简单易用,易于计算,可能有助于在 PCI 前评估 CA-AKI 风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf6/9296582/c948ea465305/41598_2022_16690_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验